No Data
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Maintains Target Price $80
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Cuts Target Price to $80
TransMedics Group: Balancing Long-term Promise With Short-term Uncertainty – Hold Rating Maintained
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $125
TransMedics Group Is Maintained at Overweight by Piper Sandler
70178686 : 35-55 good
102156718 : Normal. Just wait for next 2-3 earnings. It will be back to 100+.
70194969 OP 102156718 : Really ? I have 3000 shares
102156718 70194969 OP : I have 100k shares. Just leave it and stop trading.
70194969 OP 102156718 : Wow my price at $85
View more comments...